The biotech sector is well known for its M&A activity, but billionaire fund managers don’t seem to be attracted by the frenzy.
Keep Reading →
February 5 - Hedge Funds, News
“U.S. stocks traded mostly higher Wednesday, with energy leading, as investors digested economic data and the start of the United Kingdom's divorce from the European Union.
Keep Reading →
March 29 - Commodities, Gold, Market Movers, News
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) shares have popped almost 19% in the pre-market after the company released positive results from two studies.
Keep Reading →
March 29 - Market Movers, News
Hedge fund managers like David Einhorn, Dan Loeb, or Carl Icahn became billionaires through reaping large profits for their investors, which is why piggybacking their stock picks...
Keep Reading →
November 25 - Hedge Funds, News
Bringing something new to the table is something that seems to be difficult these days, considering that many things have already been done, have already been invented, and have...
Keep Reading →
October 26 - Hedge Funds, Lists, News
There probably is no other sector that has burned hedge funds this year as bad as healthcare has.
Keep Reading →
April 12 - Hedge Fund Analysis, Hedge Funds, News
There are several ways to beat the market, and investing in small cap stocks has historically been one of them.
Keep Reading →
November 24 - Hedge Funds, News
It's the start of another week of what should amount to compelling trading activity and shares of Amazon.com, Inc.
Keep Reading →
November 2 - Market Movers, News
With the earnings season in progress, a number of stocks are registering significant moves on the back of earnings releases and other news.
Keep Reading →
October 29 - Earnings Report, Market Movers, News, Tech
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) is up more than 42% after reporting successful results of its cystic fibrosis treatment.
Keep Reading →
June 24 - Market Movers, News
Outerwall, Pandora, Achillion, hedge funds: It’s no secret that at Insider Monkey, we track hedge funds (discover why here).
Keep Reading →
October 11 - Hedge Funds, News
It's really amazing to think about how far we've come over even the past decade in the health-care arena.
Keep Reading →
September 23 - News
Ray Dalio manages the world's largest hedge fund, Bridgewater Associates. It has a tremendous track record, so when the man talks about markets, people usually listen.
Keep Reading →
September 23 - Hedge Funds
There are few, if any, businesses in the world where innovation isn't the top priority.
Keep Reading →
September 14 - News
Yesterday, shareholders in chipmaker Advanced Micro Devices, Inc. (NYSE:AMD) and defense contractor SAIC, Inc. (NYSE:SAI) got what seemed like bad news.
Keep Reading →
September 13 - News
As fast as we can type this, Phill Gross and Robert Atchinson's hedge fund, Adage Capital Partners, disclosed ownership of about 3.7 million shares of Onyx Pharmaceuticals, ...
Keep Reading →
September 9 - News
If you were to ask many investors, hedge funds are viewed as delayed, outdated investment vehicles of an era lost to time.
Keep Reading →
August 29 - News
One of the company's ushering in the next generation of hepatitis-C treatment is Gilead Sciences, Inc. (NASDAQ:GILD).
Keep Reading →
August 28 - News
In the 21st century investor’s toolkit, there are tons of metrics market participants can use to track the equity markets.
Keep Reading →
August 26 - News
In the 21st century investor’s toolkit, there are tons of metrics shareholders can use to track publicly traded companies.
Keep Reading →
August 26 - News
In the 21st century investor’s toolkit, there are dozens of indicators investors can use to analyze Mr. Market.
Keep Reading →
August 26 - News
In the financial world, there are dozens of gauges shareholders can use to analyze stocks. Two of the most under-the-radar are hedge fund and insider trading sentiment.
Keep Reading →
August 26 - News
If you were to ask many investors, hedge funds are assumed to be useless, old investment tools of a period lost to current times.
Keep Reading →
August 23 - News
In after hours trading on April 18, a few hours after the release of my previous article focusing on Exelixis, Inc.
Keep Reading →
August 23 - News
If you've ever taken the time to really follow the biopharmaceutical sector, you know very well that failures are a dime a dozen, and success stories are few and far between.
Keep Reading →
August 19 - News
The S&P 500 includes 500 of the biggest stocks in the market.
Keep Reading →
August 5 - News
Exchange-traded funds offer a convenient way to invest in sectors or niches that interest you.
Keep Reading →
August 1 - News
Cystic fibrosis (CF), a genetic disorder that affects the lungs, the pancreas, liver, and intestine, is the second most common inherited disorder in the United States, after sickle...
Keep Reading →
August 1 - News
With the SPDR S&P Biotech Index up 29% over the trailing-12-month period, it's evident that investment dollars are willingly flowing into the biotech sector.
Keep Reading →
July 29 - News
Biotechnology stocks are usually valued on the potential of their pipelines, especially if there is no drug already in the market.
Keep Reading →
July 29 - News
Gilead Sciences, Inc. (NASDAQ:GILD)' shares surged over 5% in after-hours trading on Thursday after the company announced its second-quarter earnings before giving up some of...
Keep Reading →
July 29 - News
Johnson & Johnson (NYSE:JNJ) reported its second quarter on Tuesday, and turned in some positive numbers. Revenue grew 8.5%, year-over-year, up to $17.9 billion.
Keep Reading →
July 19 - News
To prove my point, I looked at the multi-year chart and picked out some of the peaks.
Keep Reading →
July 1 - News
When the stock price of a company increases significantly, investors are curious to know whether it is likely to increase further.
Keep Reading →
June 27 - News
Hepatitis-C is a contagious virus that attacks the liver and can be found in acute or chronic forms.
Keep Reading →
June 24 - News
Our job here is to examine companies through an investing perspective.
Keep Reading →
June 12 - News
A recent report by EvaluatePharma claims that sales of orphan drugs -- ones that target rare diseases -- will grow at twice the rate of the overall prescription market.
Keep Reading →
May 30 - News
After a 12-week run of seeing its share price rise for the week, Johnson & Johnson (NYSE:JNJ) stock fell last week.
Keep Reading →
May 29 - News
Is Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) the right investment to pursue these days? The smart money is getting less optimistic.
Keep Reading →
May 29 - News
Combining nice dividends with a growing industry that comprises roughly one-fifth of the nation's GDP should make for an attractive stock -- in theory.
Keep Reading →
May 15 - News
What's the source of your investment strategy? Many look to great investors like Warren Buffett for guidance on how to invest.
Keep Reading →
May 13 - News
Janus Fund (JANDX) bares the name of the fund family behind it. The flagship offering focuses on growth.
Keep Reading →
May 1 - Hedge Funds
Dividend stocks can be a great addition to your portfolio, especially pharmaceutical dividend stocks that offer a bit of stability in rocky times.
Keep Reading →
May 1 - News
Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) have appreciated significantly in 2013 so far, and it seems that the trend might continue for the rest of the year.
Keep Reading →
April 30 - News
Biotechs with market caps of a billion dollars or more are a dime a dozen. Well, actually, they're more like $12 billion or more a dozen, but you get the point.
Keep Reading →
April 23 - News
They're demanding. They take risks -- but only calculated ones. And they ask lots of penetrating questions to understand as much as possible before putting a dime on the line.
Keep Reading →
April 22 - News
As I mentioned previously in Part 1, it was an incredibly busy week for the biotech sector.
Keep Reading →
April 20 - News
There are many biotech stocks to choose from that have long-lasting value.
Keep Reading →
April 19 - News
Exchange-traded funds offer a convenient way to invest in sectors or niches that interest you.
Keep Reading →
April 12 - News